blogs | science
AI Protocol Writing for Clinical Trials: What to Know in 2026
AI protocol writing for clinical trials is changing how regulatory teams draft and review protocols. A guide to capabilities, limitations, and evaluation criteria.
Pharma Cloud
Unobio
Discovery to approval.
One platform.
Unobio unifies R&D and commercialization into a single AI-native surface.
60%faster protocol drafting
2xfaster hypothesis-to-experiment cycles
40%less duplication across workflows
3ximprovement in decision turnaround
80%reduction in manual data reconciliation
50%shorter time to first patient dose
60%faster protocol drafting
2xfaster hypothesis-to-experiment cycles
40%less duplication across workflows
3ximprovement in decision turnaround
80%reduction in manual data reconciliation
50%shorter time to first patient dose
Two worlds. One surface.
Unobio bridges commercialization and scientific R&D — so your pipeline moves without the handoffs, rework, and data silos.
Commercialization
From filing to approval, automated.
Regulatory intelligence, FDA submission prep, and commercial analytics — unified in one workspace that keeps every program on track.
- AI-assisted protocol drafting
- Cross-section consistency checks
- AI-driven market sizing and launch planning
- Pipeline-wide status at a glance
Scientific R&D
Discover faster. With AI at every step.
AI-powered drug discovery workflows, literature search, and compound analysis — all connected to your commercialization timeline.
- AI-powered target identification
- Compound screening and binding prediction
- Automated literature review with citations
- Toxicology risk assessment
Core capabilities
Every tool a pharmaceutical team needs — from molecule to market.
AI-Powered Discovery
Identify targets, screen compounds, and predict binding affinity — accelerated by models trained on proprietary pharma data.
Protocol Writing
Study-specific protocol outlines, source-grounded drafting, and cross-section consistency checks that remove manual writing bottlenecks.
AI Commercialization
Market sizing, launch sequencing, and competitive intelligence — powered by AI models trained on real-world pharma data.
Unified Data Layer
One source of truth connecting R&D outputs to commercial milestones. No handoffs, no rework, no data silos.
The future of pharma isn't more tools. It's one platform that thinks like you do.
Unobio brings AI-native workflows to every stage of the pipeline — so your team focuses on science, not software.
Latest Articles
View all →
Ready to see the platform?
30-minute walkthrough. No slides. Just the product — tailored to your pipeline.
Request a Demo